Secukinumab-induced vitiligo: A new case report and review of the literature

Therapie. 2023 Nov-Dec;78(6):754-756. doi: 10.1016/j.therap.2022.12.004. Epub 2022 Dec 9.
No abstract available

Keywords: Biologic agents; Psoriasis; Vitiligo.

Publication types

  • Review
  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal, Humanized / adverse effects
  • Humans
  • Male
  • Psoriasis* / chemically induced
  • Psoriasis* / drug therapy
  • Severity of Illness Index
  • Treatment Outcome
  • Vitiligo* / chemically induced

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • secukinumab